Human flavivirus infections elicit virus species-specific and cross-reactive immune responses. The flavivirus envelope (E) glycoprotein is the primary antigen inducing protective immunity; however, the presence of cross-reactive antibodies in human sera creates problems for serodiagnosis. Using a West Nile virus-like particle system, we performed mutagenesis across all three E protein functional domains to identify epitope determinants for a panel of monoclonal antibodies (mAbs) raised against different flaviviruses and exhibiting diverse patterns of cross-reactivity. Residues within the highly conserved fusion peptide were the only epitope determinants identified and were important not only for broadly cross-reactive mAbs recognizing all of the medically important flavivirus serocomplexes, but also for less-broad, complex-reactive mAbs. Moreover, different substitutions at specific fusion peptide residues produced highly variable effects on antibody reactivity and virus-like particle secretion. These results support and extend the conclusion that the fusion peptide region constitutes an immunodominant epitope stimulating antibodies with diverse patterns of cross-reactivity.
AllisonS. L.,
SchalichJ.,
StaisnyK.,
MandlC. W.,
HeinzF. X.2001; Mutational evidence of an internal fusion peptide in the flavivirus envelope protein. J Virol 75:4268–4275[CrossRef]
CalisherC. H.,
KarabatsosN.,
DalrympleJ. M.,
ShopeR. E.,
PorterfieldJ. S.,
WestawayE. G.,
BrandtW. E.1989; Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70:37–43[CrossRef]
ChangG. J.,
HuntA. R.,
DavisB. S.2000; A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol 74:4244–4252[CrossRef]
CrillW. D.,
RoehrigJ. T.2001; Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75:7769–7773[CrossRef]
DavisB. S.,
ChangG. J.,
CroppB.,
RoehrigJ. T.,
MartinD. A.,
MitchellC. J.,
BowenR.,
BuningM. L.2001; West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol 75:4040–4047[CrossRef]
GoncalvezA. P.,
PurcellR. H.,
LiC. J.2004; Epitope determinants of a chimpanzee Fab fragment that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. J Virol 78:12919–12928[CrossRef]
HolmesD. A.,
PurdyD. E.,
ChaoD.,
NogaA. J.,
ChangG. J.2005; Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles of virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J Clin Microbiol 43:3227–3236[CrossRef]
LanciottiR. S.,
RoehrigJ. T.,
DeubelV.,
SmithJ.,
ParkerM.,
SteeleK.,
CriseB.,
VolpeK. E.,
CrabtreeM. B.other authors1999; Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333–2337[CrossRef]
LindenbachB. D.,
RiceC. M.2001; Flaviviridae : the viruses and their replication. In Fields Virology , 4th edn. pp 991–1041 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia, PA: Lippincott Williams & Wilkins;
MackenzieJ. S.,
GublerD. J.,
PetersenL. R.2004; Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10:S98–S109[CrossRef]
MartinD. A.,
BiggerstaffB. J.,
AllenB.,
JohnsonA. J.,
LanciottiR. S.,
RoehrigJ. T.2002; Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 9:544–549
ModisY.,
OgataS.,
ClementsD.,
HarrisonS. C.2003; A ligand-binding pocket in the DEN virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986–6991[CrossRef]
ReyF. A.,
HeinzF. X.,
MandlC.,
KunzK.,
HarrisonS. C.1995; The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291–298[CrossRef]
RoehrigJ. T.,
BolinR. A.,
KellyR. G.1998; Monoclonal antibody mapping of the envelope glycoprotein of the DEN 2 virus, Jamaica. Virology 246:317–328[CrossRef]
TeshR. B.,
Travassos de RosaP. A. A.,
GuzmanH.,
AraujoT. P.,
XiaoS.-Y.2002; Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 8:245–251[CrossRef]
ThrosbyM.,
GeuijenC.,
GoudsmitJ.,
BakkerA. Q.,
KorimbocusJ.,
KramerR. A.,
Clijsters-van der HorstM.,
de JongM.,
JongeneelenM.other authors2006; Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile virus. J Virol 80:6982–6992[CrossRef]
ZhangS.,
LiL.,
WoodsenS. E.,
HuangC. Y.-H.,
KinneyR. M.,
BarrettA. D. T.,
BeasleyD. W. C.2006; A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology 353:35–40[CrossRef]